Energy Balance and Weight Gain With Ivacaftor Treatment

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

November 30, 2016

Conditions
Cystic Fibrosis
Trial Locations (1)

19104

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
collaborator

Vertex Pharmaceuticals Incorporated

INDUSTRY

lead

Children's Hospital of Philadelphia

OTHER

NCT02141464 - Energy Balance and Weight Gain With Ivacaftor Treatment | Biotech Hunter | Biotech Hunter